Compile Data Set for Download or QSAR
maximum 50k data
Found 434 of ec50 data for polymerid = 1066,9837,9838
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229588(US9334279, 1064)
Affinity DataEC50:  0.300nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229560(US9334279, 1036)
Affinity DataEC50:  0.300nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229584(US9334279, 1060)
Affinity DataEC50:  0.300nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229593(US9334279, 1069)
Affinity DataEC50:  0.300nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229564(US9334279, 1040)
Affinity DataEC50:  0.300nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229591(US9334279, 1067)
Affinity DataEC50:  0.300nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229567(US9334279, 1043)
Affinity DataEC50:  0.300nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229576(US9334279, 1052)
Affinity DataEC50:  0.300nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229575(US9334279, 1051)
Affinity DataEC50:  0.300nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229574(US9334279, 1050)
Affinity DataEC50:  0.300nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229561(US9334279, 1037)
Affinity DataEC50:  0.300nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229569(US9334279, 1045)
Affinity DataEC50:  0.300nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229547(US9334279, 1023)
Affinity DataEC50:  0.400nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229547(US9334279, 1023)
Affinity DataEC50:  0.460nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229568(US9334279, 1044)
Affinity DataEC50:  0.75nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229571(US9334279, 1047)
Affinity DataEC50:  0.75nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229576(US9334279, 1052)
Affinity DataEC50:  0.75nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229578(US9334279, 1054)
Affinity DataEC50:  0.75nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229583(US9334279, 1059)
Affinity DataEC50:  0.75nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229583(US9334279, 1059)
Affinity DataEC50:  0.75nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229584(US9334279, 1060)
Affinity DataEC50:  0.75nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229555(US9334279, 1031 | US9334279, 1062)
Affinity DataEC50:  0.75nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229567(US9334279, 1043)
Affinity DataEC50:  0.75nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229565(US9334279, 1041)
Affinity DataEC50:  0.75nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229564(US9334279, 1040)
Affinity DataEC50:  0.75nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229562(US9334279, 1038)
Affinity DataEC50:  0.75nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229560(US9334279, 1036)
Affinity DataEC50:  0.75nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229559(US9334279, 1035)
Affinity DataEC50:  0.75nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229559(US9334279, 1035)
Affinity DataEC50:  0.75nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229558(US9334279, 1034)
Affinity DataEC50:  0.75nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229557(US9334279, 1033)
Affinity DataEC50:  0.75nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229555(US9334279, 1031 | US9334279, 1062)
Affinity DataEC50:  0.75nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229549(US9334279, 1025)
Affinity DataEC50:  0.75nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229548(US9334279, 1024)
Affinity DataEC50:  0.75nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229545(US9334279, 1021)
Affinity DataEC50:  0.75nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229525(US9334279, 1001)
Affinity DataEC50:  0.75nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229565(US9334279, 1041)
Affinity DataEC50:  0.75nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229590(US9334279, 1066)
Affinity DataEC50:  0.75nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229541(US9334279, 1017)
Affinity DataEC50:  0.820nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229541(US9334279, 1017)
Affinity DataEC50:  0.950nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Hoffmann-La Roche

US Patent
LigandPNGBDBM65581(US9693997, 1)
Affinity DataEC50:  1nMAssay Description:Plasmids expressing HCV E1 and E2 envelope proteins of GT1a H77 strain (Proc Natl Acad Sci USA 1997 94:8738-43) or GT1b Con1 strain (Science 1999 285...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229529(US9334279, 1005)
Affinity DataEC50:  1.48nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229529(US9334279, 1005)
Affinity DataEC50:  1.71nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Hoffmann-La Roche

US Patent
LigandPNGBDBM70703(US9693997, 221)
Affinity DataEC50:  3nMAssay Description:Plasmids expressing HCV E1 and E2 envelope proteins of GT1a H77 strain (Proc Natl Acad Sci USA 1997 94:8738-43) or GT1b Con1 strain (Science 1999 285...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229574(US9334279, 1050)
Affinity DataEC50:  3nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229577(US9334279, 1053)
Affinity DataEC50:  3nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229577(US9334279, 1053)
Affinity DataEC50:  3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229578(US9334279, 1054)
Affinity DataEC50:  3nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229579(US9334279, 1055)
Affinity DataEC50:  3nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229579(US9334279, 1055)
Affinity DataEC50:  3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 434 total ) | Next | Last >>
Jump to: